Corcept Therapeutics Incorporated

CORTNASDAQHealthcare● Active

$73.89

+$1.27(+1.75%)

Market Cap$7.9B

P/E Ratio—

52W High$91

52W Low$28.66

Avg Volume1.4M

Open$72.88

Beta0.50

Overview

Corcept Therapeutics Incorporated (CORT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CORT · net income · updated Jun 8, 2026

Core profitability metrics

CORT · net income · margin · TTM · CAGR

Net income was $99.7M for FY2025 (fiscal year ending 2025-12-31), down 28.7% year-over-year. Net profit margin was 13.1%. Based on available data, Corcept Therapeutics Incorporated has been profitable since at least 2016.

FY2025 Net Income$99.7M▼ -28.7% YoY

Trailing 12M (TTM)$47.9Mtrailing 4 quarters sum

Net Profit Margin13.1%$99.7M ÷ $761.4M

YoY Change-28.7%—

5-Year CAGR-1.2%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2016

▸ FMP /income-statement · Annual · CORT net income history · CORT profit margin

Annual net income data

CORT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$99.7M▼ 28.7%13.1%$761.4M

FY2024$139.7M▲ +31.6%20.7%$675.0M

FY2023$106.1M▲ +4.7%22.0%$482.4M

FY2022$101.4M▼ 9.9%25.2%$401.9M

FY2021$112.5M▲ +6.1%30.7%$366.0M

Net income vs peers (Healthcare)

CORT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Corcept Therapeutics IncorporatedYOU

CORT

$99.7M-28.7%13.1%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Corcept Therapeutics Incorporated (CORT) reported net income of $99.7M for FY2025 (fiscal year ending 2025-12-31), down 28.7% year-over-year. The net profit margin was 13.1% — meaning the company kept $0.13 of every dollar of revenue as profit.

Based on available data, Corcept Therapeutics Incorporated has been profitable since at least 2016. Net income reached a peak of $139.7M in FY2024. Data available for 15 fiscal years.

Corcept Therapeutics Incorporated's net profit margin was 13.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Corcept Therapeutics Incorporated net worth" — the company's market capitalization is a separate figure from CORT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CORT net income · 5 questions

Corcept Therapeutics Incorporated is profitable. The company reported net income of $99.7M for FY2025, a net profit margin of 13.1%. Net income was down 28.7% year-over-year. Based on available data, Corcept Therapeutics Incorporated has been profitable since at least 2016.

is CORT profitabledoes CORT make a profitCORT profitabilityCORT profitable company

▸ Source: FMP /income-statement · GAAP · Corcept Therapeutics Incorporated · Corcept Therapeutics Incorporated SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026